Together, these findings demonstrate that ARID1A-deficiency leads to CXCL10 and CXCL11 downregulation in organoids, while Li et al showed this downregulation drives immune exclusion in colon cancer. This evidence concerns the gene CXCL10 and malignant colon neoplasm.